PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22929971-1	2013	We synthesized a novel imidazopyridine analogue, a PI3Kalpha inhibitor HS-173 and investigated anti-cancer capacity in human cancer cells.	imidazopyridine	23-38	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	Homo sapiens	51-60	
22155744-1	2012	Potentiation of anti-breast cancer activity of an imidazopyridine-based PI3Kalpha inhibitor, HS-104, was investigated in human breast cancer cells.	imidazopyridine	50-65	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	Homo sapiens	72-81	
28800461-7	2017	The western blot assay indicated that 1i is more effective than HS-173, an imidazopyridine-based PI3Ka inhibitor, in reducing the levels of phospho-Akt.	imidazopyridine	75-90	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	Homo sapiens	97-102